Vitaccess Ltd: Clinical Trials

9 trials sponsored by Vitaccess Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Vitaccess Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Non-interventional, digital, patient-reported, study - Choroidal Melanoma, Indeterminate Lesions
Active not recruitingAura Biosciences152025-11-122026-10-22
Vitaccess Real CIDP Registry
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
Not yet recruitingVitaccess Ltd3002025-07-312025-06-05
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Encorafenib + Binimetinib - Metastatic Melanoma, BRAF V600 Mutation Positive
Active not recruitingPierre Fabre Ltd502025-07-312026-04-13
Vitaccess Real MG Registry
Myasthenia Gravis
RecruitingVitaccess Ltd6002024-07-312025-07-29
A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.
Guafenesin tablets - Chronic Bronchitis
Phase 4CompletedAmerican Health Research822023-07-172026-03-20
MCT8 Deficiency Caregiver Study
Monocarboxylate Transporter 8 (MCT8) Deficiency, Allan-Herndon-Dudley Syndrome
CompletedRare Thyroid Therapeutics International AB212022-08-232024-04-25
The Impact of Myasthenia Gravis in the Real World
Myasthenia Gravis
CompletedVitaccess Ltd28472019-12-122024-06-03
The Impact of Charcot-Marie-Tooth Disease in the Real World
Charcot-Marie-Tooth Disease
CompletedVitaccess Ltd33212018-10-092024-11-14
The Impact of Melanoma and Drug Treatment in the Real World
Melanoma
CompletedVitaccess Ltd8192017-10-252023-03-21

Conditions studied

Autoimmune Diseases (2)  ·  Melanoma (2)  ·  Myasthenia Gravis (2)  ·  Nervous System Diseases (2)  ·  Allan-Herndon-Dudley syndrome (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Bronchitis, Chronic (1)  ·  Charcot-Marie-Tooth Disease (1)  ·  Eye Neoplasms (1)  ·  Financial Stress (1)  ·  Immune System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Neuromuscular Junction Diseases (1)  ·  Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)

Interventions

Acetylcysteine (1)  ·  binimetinib (1)  ·  encorafenib (1)

Countries

United Kingdom (6)  ·  United States (2)  ·  Australia (1)

Top investigators

Mark JW Larkin, PhD (4)  ·  Andrew Furness, MBBS, MRCP, PhD (1)  ·  Mark Larkin, PhD (1)  ·  Selwyn Spangenthal, MD (1)  ·  Tarandeep Singh Matharu, MPharm, PgCert (1)

Results publications

PMID 36005469, PMID 36720569, PMID 37169499, PMID 39068745